Sofi Damjanovska1, Carson Smith2, Ismail Sayin1, Christopher J Burant3, Stefan Gravenstein4, David H Canaday5. 1. Department of Medicine, Cleveland VA Medical Center, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106-4984, United States. 2. Department of Pathology, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106-4984, United States. 3. Case Western Reserve University School of Nursing, Cleveland VA Medical Center, 10900 Euclid Ave, Cleveland, OH 44106-7343, United States. 4. Brown University, Providence VA Medical Center, Providence, RI 02912, United States. 5. Department of Medicine, Cleveland VA Medical Center, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106-4984, United States. Electronic address: Dxc44@case.edu.
Abstract
BACKGROUND: Seasonal influenza vaccines approved and offered in the United States have varying reported degrees of effectiveness year over year and between manufacturers. Influenza vaccines produced from live virus may include single stranded RNA (ssRNA) that is a potent activator of the innate Toll-like receptor 7 (TLR-7) ligand. Plasmacytoid dendritic cells (pDC) can be activated by ssRNA to produce type I interferons such as IFN-α, which has been shown to have an adjuvant-like effect. OBJECTIVE: Our aim was to determine if IFN-α induction in peripheral blood mononuclear cells (PBMCs) exposed to eight different commercial influenza vaccines is a pDC-dependent process mediated through TLR-7 signaling. RESULTS: We demonstrate the ability of multiple vaccines to induce IFN-α in a TLR-7-dependent fashion. A number of vaccines however lacked IFN-α induction. The significance of these differences between vaccines is unclear, since all the approved vaccine formulations offer some degree of protection. Published by Elsevier Ltd.
BACKGROUND: Seasonal influenza vaccines approved and offered in the United States have varying reported degrees of effectiveness year over year and between manufacturers. Influenza vaccines produced from live virus may include single stranded RNA (ssRNA) that is a potent activator of the innate Toll-like receptor 7 (TLR-7) ligand. Plasmacytoid dendritic cells (pDC) can be activated by ssRNA to produce type I interferons such as IFN-α, which has been shown to have an adjuvant-like effect. OBJECTIVE: Our aim was to determine if IFN-α induction in peripheral blood mononuclear cells (PBMCs) exposed to eight different commercial influenza vaccines is a pDC-dependent process mediated through TLR-7 signaling. RESULTS: We demonstrate the ability of multiple vaccines to induce IFN-α in a TLR-7-dependent fashion. A number of vaccines however lacked IFN-α induction. The significance of these differences between vaccines is unclear, since all the approved vaccine formulations offer some degree of protection. Published by Elsevier Ltd.
Authors: Derek T O'Hagan; Gary S Ott; Gary Van Nest; Rino Rappuoli; Giuseppe Del Giudice Journal: Expert Rev Vaccines Date: 2013-01 Impact factor: 5.217
Authors: Robertus van Aalst; Stefan Gravenstein; Vincent Mor; Salaheddin M Mahmud; Jan Wilschut; Maarten Postma; Ayman Chit Journal: Vaccine Date: 2019-10-09 Impact factor: 3.641
Authors: Carlos A DiazGranados; Andrew J Dunning; Murray Kimmel; Daniel Kirby; John Treanor; Avi Collins; Richard Pollak; Janet Christoff; John Earl; Victoria Landolfi; Earl Martin; Sanjay Gurunathan; Richard Nathan; David P Greenberg; Nadia G Tornieporth; Michael D Decker; H Keipp Talbot Journal: N Engl J Med Date: 2014-08-14 Impact factor: 91.245